Description

Carmetadin (trimethazidine dihydrochloride) Coated Tablets with Prolonged Release 35 mg. №60

Ingredients

The active ingredient in Carmetadin is trimethazidine dihydrochloride. Each tablet contains 35 mg of trimethazidine dihydrochloride.

Dosage

The usual dosage is one tablet twice daily, preferably taken with meals. The dosage may be adjusted by your doctor depending on your condition.

Indications

Carmetadin is indicated for the treatment of ischemic heart disease (angina pectoris).

Contraindications

Carmetadin is contraindicated in patients with known hypersensitivity to trimethazidine or any other ingredient in the formulation. It is also contraindicated in patients with severe renal impairment.

Directions

Swallow the tablets whole with a full glass of water. Do not chew, crush, or break the tablets. This medication should be taken regularly to be effective. If you miss a dose, take it as soon as you remember. If it is near the time of the next dose, skip the missed dose. Do not double the dose to catch up.